208 related articles for article (PubMed ID: 31428701)
21. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.
Yu Y; Xiao CH; Tan LD; Wang QS; Li XQ; Feng YM
Br J Cancer; 2014 Feb; 110(3):724-32. PubMed ID: 24335925
[TBL] [Abstract][Full Text] [Related]
23. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.
Cao Y; Cao W; Qiu Y; Zhou Y; Guo Q; Gao Y; Lu N
Pharmacol Res; 2020 Sep; 159():104981. PubMed ID: 32492489
[TBL] [Abstract][Full Text] [Related]
24. Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes.
You J; Li M; Cao LM; Gu QH; Deng PB; Tan Y; Hu CP
QJM; 2019 Aug; 112(8):581-590. PubMed ID: 31106370
[TBL] [Abstract][Full Text] [Related]
25. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
26. Cucurbitacin I (JSI-124)-dependent inhibition of STAT3 permanently suppresses the pro-carcinogenic effects of active breast cancer-associated fibroblasts.
Al-Harbi B; Aboussekhra A
Mol Carcinog; 2021 Apr; 60(4):242-251. PubMed ID: 33621387
[TBL] [Abstract][Full Text] [Related]
27. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
28. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
29. NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.
Xu X; Yan Q; Wang Y; Dong X
Oncol Rep; 2017 Jan; 37(1):449-457. PubMed ID: 27840993
[TBL] [Abstract][Full Text] [Related]
30. Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts.
Kogure A; Naito Y; Yamamoto Y; Yashiro M; Kiyono T; Yanagihara K; Hirakawa K; Ochiya T
PLoS One; 2020; 15(6):e0234613. PubMed ID: 32555715
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets.
Kim BG; Kang S; Han HH; Lee JH; Kim JE; Lee SH; Cho NH
Oncotarget; 2016 May; 7(19):27468-78. PubMed ID: 27027350
[TBL] [Abstract][Full Text] [Related]
32. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
34. MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Eiro N; Cid S; Aguado N; Fraile M; de Pablo N; Fernández B; Domínguez F; González LO; Vizoso FJ
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396463
[TBL] [Abstract][Full Text] [Related]
35. Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma.
Hutchenreuther J; Vincent K; Norley C; Racanelli M; Gruber SB; Johnson TM; Fullen DR; Raskin L; Perbal B; Holdsworth DW; Postovit LM; Leask A
Matrix Biol; 2018 Dec; 74():52-61. PubMed ID: 29885461
[TBL] [Abstract][Full Text] [Related]
36. Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development.
Dai H; Xu W; Wang L; Li X; Sheng X; Zhu L; Li Y; Dong X; Zhou W; Han C; Mao Y; Yao L
Breast Cancer Res; 2023 Jul; 25(1):90. PubMed ID: 37507768
[TBL] [Abstract][Full Text] [Related]
37. Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
Zhu K; Cai L; Cui C; de Los Toyos JR; Anastassiou D
PLoS Comput Biol; 2021 Jul; 17(7):e1009228. PubMed ID: 34283835
[TBL] [Abstract][Full Text] [Related]
38. Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
Hsu HC; Liu LC; Wang HY; Hung CM; Lin YC; Ho CT; Way TD
PLoS One; 2017; 12(1):e0164661. PubMed ID: 28060811
[TBL] [Abstract][Full Text] [Related]
39. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
[TBL] [Abstract][Full Text] [Related]
40. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
